|
Emcure Pharmaceuticals Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
27270.80 Cr.
|
P/BV
|
6.62
|
Book Value (Rs.)
|
217.28
|
|
52 Week High/Low (Rs.)
|
1520/889
|
FV/ML
|
10/1
|
P/E(X)
|
40.03
|
|
Bookclosure
|
14/08/2025
|
EPS (Rs.)
|
35.94
|
Div Yield (%)
|
0.21
|
|
| Months | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | |
| PER SHARE RATIOS | | | | |
| | | | | |
| Basic EPS (Rs.) | 36.43 | 27.54 | 29.42 | 36.62 |
| Diluted EPS (Rs.) | 36.43 | 27.54 | 29.42 | 36.62 |
| Cash EPS (Rs.) | 57.61 | 46.37 | 45.45 | 52.38 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 234.65 | 172.33 | 146.51 | 116.90 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 234.65 | 172.33 | 146.51 | 116.90 |
| Revenue From Operations / Share (Rs.) | 416.71 | 367.55 | 330.98 | 323.77 |
| PBDIT / Share (Rs.) | 81.36 | 71.03 | 67.85 | 77.05 |
| PBIT / Share (Rs.) | 61.09 | 53.78 | 53.47 | 63.51 |
| PBT / Share (Rs.) | 51.26 | 40.14 | 41.32 | 53.77 |
| Net Profit / Share (Rs.) | 37.34 | 29.12 | 31.07 | 38.85 |
| NP After MI And SOA / Share (Rs.) | 35.96 | 27.50 | 29.42 | 36.62 |
| | | | | |
| PROFITABILITY RATIOS | | | | |
| | | | | |
| PBDIT Margin (%) | 19.52 | 19.32 | 20.49 | 23.79 |
| PBIT Margin (%) | 14.65 | 14.63 | 16.15 | 19.61 |
| PBT Margin (%) | 12.30 | 10.92 | 12.48 | 16.60 |
| Net Profit Margin (%) | 8.95 | 7.92 | 9.38 | 11.99 |
| NP After MI And SOA Margin (%) | 8.62 | 7.48 | 8.88 | 11.30 |
| Return on Networth / Equity (%) | 15.32 | 16.87 | 21.27 | 33.31 |
| Return on Capital Employeed (%) | 20.80 | 21.20 | 26.46 | 37.06 |
| Return On Assets (%) | 8.27 | 6.38 | 7.97 | 10.92 |
| Long Term Debt / Equity (X) | 0.04 | 0.25 | 0.29 | 0.36 |
| Total Debt / Equity (X) | 0.16 | 0.70 | 0.87 | 1.05 |
| Asset Turnover Ratio (%) | 0.98 | 0.91 | 0.93 | 0.00 |
| | | | | |
| LIQUIDITY RATIOS | | | | |
| | | | | |
| Current Ratio (X) | 1.71 | 1.33 | 1.27 | 1.15 |
| Quick Ratio (X) | 0.98 | 0.85 | 0.81 | 0.66 |
| Inventory Turnover Ratio (X) | 4.57 | 0.91 | 0.80 | 0.00 |
| Dividend Payout Ratio (NP) (%) | 0.00 | 10.89 | 6.79 | 8.19 |
| Dividend Payout Ratio (CP) (%) | 0.00 | 6.69 | 4.56 | 5.98 |
| Earning Retention Ratio (%) | 0.00 | 89.11 | 93.21 | 91.81 |
| Cash Earning Retention Ratio (%) | 0.00 | 93.31 | 95.44 | 94.02 |
| | | | | |
| COVERAGE RATIOS | | | | |
| | | | | |
| Interest Coverage Ratio (%) | 8.77 | 5.43 | 5.74 | 7.92 |
| Interest Coverage Ratio (Post Tax) (%) | 5.08 | 3.27 | 3.66 | 4.99 |
| | | | | |
| VALUATION RATIOS | | | | |
| | | | | |
| Enterprise Value (Cr.) | 21089.51 | 0.00 | 0.00 | 0.00 |
| EV / Net Operating Revenue (X) | 2.67 | 0.00 | 0.00 | 0.00 |
| EV / EBITDA (X) | 13.68 | 0.00 | 0.00 | 0.00 |
| MarketCap / Net Operating Revenue (X) | 2.57 | 0.00 | 0.00 | 0.00 |
| Retention Ratios (%) | 0.00 | 89.10 | 93.20 | 91.80 |
| Price / BV (X) | 4.57 | 0.00 | 0.00 | 0.00 |
| Price / Net Operating Revenue (X) | 2.57 | 0.00 | 0.00 | 0.00 |
| EarningsYield | 0.03 | 0.00 | 0.00 | 0.00 |
